Sessions

All Sessions
keyboard_arrow_down
filter_list Show filters Hide filters
  • All Tracks
  • L2
  • L3
  • L4
  • C2
  • Mezzanine
Conference & Exhibition Open
event_note Monday, 05 Oct 2020
query_builder 8:30 - 18:00
card_travel Exhibition
mic English
Conference & Exhibition Open
Delegate Registration 8:30-9:30
Welcome to BioForward 2020
event_note Monday, 05 Oct 2020
query_builder 9:30 - 9:35
card_travel Keynote
mic English
Welcome to BioForward 2020
Speakers
John Harris
CEO
OBN (UK) Ltd
star star star star star
HR Drop In Clinic
event_note Monday, 05 Oct 2020
query_builder 9:35 - 11:00
card_travel Drop In Session
mic English
HR Drop In Clinic
Panel: Selecting the Right Board for your Business
event_note Monday, 05 Oct 2020
query_builder 9:35 - 10:20
card_travel Panel Discussion
mic English
Panel: Selecting the Right Board for your Business
One of the biggest challenges for any company CEO is ensuring they appoint the right individuals to their Board, to achieve the best mix of requisite skills, experience and competencies that can guide and support the long-term success of the organisation.

The board will be responsible for many key decisions within the organisation including its control and accountability systems, final approval of the corporate strategy, risk management and legal compliance, approving and monitoring the progress of major capital expenditure, capital management, and acquisitions and divestitures.  

It is important that a potential Board member properly evaluates the organisation before committing, ensuring that their skills and experience fill a gap and compliment the other Board members.  

This panel will share information that will guide you on the key areas to consider when forming your board, and potential pitfalls to be aware of, including:

 
  • The importance of considering the composition of a board and the dynamics of its personalities; does the team have the patience and fortitude to work through pre-revenue phases?
  • Ensure you achieve a a good balance of values between scientific research and the commercial and financial skills and experience required to nurture the growth of a pre-revenue business
  • How will the Board be remunerated/rewarded for the considerable time they will devote to your organisation – what can be offered to board members instead of cash?
  • Are your Board members truly passionate about the science that is driving the company?
  • What is their attitude to risk?  A considered appetite for risk and an understanding of the commercialisation process, marketing, and business can be a great attribute.
  • How to deal with a conflict of interest - at board level in the life sciences industry there is generally a smaller pool of appropriate board candidates to choose from, so it is important to ensure all conflicts are declared and dealt with appropriately
  • Choose your Chair with care – it is important that they are highly experienced in the area you are specialising in, hold considerable gravitas in the industry and act as a respected figurehead for the business
Panel: What's New in the Regulatory Landscape?
event_note Monday, 05 Oct 2020
query_builder 10:20 - 11:10
card_travel Panel Discussion
mic English
Panel: What's New in the Regulatory Landscape?
All company owners in the life sciences must maintain a comprehensive, real-time view of the regulations that exist in their industry and ensure that their compliance programs are full integrated into their evolving business strategies.
 

Regulatory matters must have a front and centre focus throughout the R&D process as well as when new business relationships are explored.  By ensuring you are fully compliant you are better supporting your teams and the ongoing work of your organisation.

This panel has been designed to review all that is new in the regulatory landscape of the life sciences industry; and as the UK looks forward to its future outside the EU,  we will also  address the key areas set to change or be impacted post the transition on 31st December 2020. 

Key topics will include:
  • An insight into the updates in the published Medicines and Medical Devices Bill – what does this mean for UK life sciences companies after we transition out of the EU, particularly regarding human medicines regulation, clinical trials, and medical devices
  • What are the the regulatory updates in areas such as using artificial intelligence in treatments?
  • How can the UK break new ground in complex clinical trials – will the implementation of new regulations make us a more attraction location for external companies?
  • What aspects of current bureaucratic processes can and should be modified, reduced or eliminated to make the UK system a faster, cheaper and more streamlined market?
Networking Break and Partnering Meetings
event_note Monday, 05 Oct 2020
query_builder 11:10 - 11:30
card_travel Social
mic English
Networking Break and Partnering Meetings
BioLearn Masterclass: How the Drug Discovery Industry Works
event_note Monday, 05 Oct 2020
query_builder 11:30 - 12:15
card_travel BioLearn Masterclass
mic English
BioLearn Masterclass: How the Drug Discovery Industry Works
This Masterclass will cover a brief overview of the following topics in a small group training-session:
  • The commercial landscape
  • Human biology, pathology and drug targets
  • Drug discovery and development
  • Industry pressures and responses
  • Industry in transition
Speakers
Edward Zanders
Owner
PharmaGuide Ltd
star star star star star
Technical Session One - An Insight into 'Adaptive' Clinical Trials
event_note Monday, 05 Oct 2020
query_builder 11:30 - 12:15
card_travel Technical Session
mic English
Technical Session One - An Insight into 'Adaptive' Clinical Trials
Sponsors
Regulatory Drop In Clinic
event_note Monday, 05 Oct 2020
query_builder 11:30 - 13:00
card_travel Drop In Session
mic English
Regulatory Drop In Clinic
Sponsors
BioLearn Masterclass: The Science of Storytelling
event_note Monday, 05 Oct 2020
query_builder 12:15 - 13:00
card_travel BioLearn Masterclass
mic English
BioLearn Masterclass: The Science of Storytelling
Technical Session Two - Strategies to Consider when Developing your Drug Product for Early Phase Clinical Trials
event_note Monday, 05 Oct 2020
query_builder 12:15 - 13:00
card_travel Technical Session
mic English
Technical Session Two - Strategies to Consider when Developing your Drug Product for Early Phase Clinical Trials
Sponsors
Networking Lunch & Partnering Meetings
event_note Monday, 05 Oct 2020
query_builder 13:00 - 14:00
card_travel Partnering
mic English
Networking Lunch & Partnering Meetings
ThermoFisher: 'Meet the Experts' Drop in Clinic
event_note Monday, 05 Oct 2020
query_builder 13:30 - 15:00
card_travel Drop In Session
mic English
ThermoFisher: 'Meet the Experts' Drop in Clinic
Sponsors
Panel: The Benefits of Growing your Business in North America
event_note Monday, 05 Oct 2020
query_builder 14:00 - 14:50
card_travel Panel Discussion
mic English
Panel: The Benefits of Growing your Business in North America
North America has one of the strongest markets in the world to offer foreign businesses, and there are a range of reasons why a life sciences company should consider a move to this thriving and growing market, as part of their medium to long term growth strategy.

One key benefit of being locate in North America is listing on NASDAQ as this can be a cost-efficient decision for smaller biotech companies, with options for lower costs that help maintain capital and fuel growth.

But when is the right time, what do you need to know and how do you go about making that move? 

This information session has been designed to give you a well-rounded insightful briefing on what a move to North America can mean to you and your organisation, along with what need to consider, including:

Why do you want to move? E.g. 
  • An increased commercial footprint
  • Enhanced access to investors
  • Availability of a new talent pool 
  • The commonalities of the markets e.g. language & culture

What you need to consider before you do e.g.
  • Employment issues - salaries & benefits
  • Taxation – there are differences between states
  • Regulatory - FDA clearance and obtaining FDA certification
  • IPO – what are the processes in North America
  • Transitioning from a start-up to emerging & growing stage of evolution
  • Export, shipping & customs issues
  • FDA clearance and approval to obtain FDA certification
  • Risk management and insurance provisions to consider
  • Incorporation or branch legal structure
  • Visas, relocation, tax, immigration issues

How can you make it work?
  • What are the best strategies for business development (particularly in medtech)?
  • How does the market work?
  • What size should your business development team be?
  • Should you be in one place or work as a network?
  • What budget should you be investing in BD?
Panel: How to Negotiate with Big Pharma
event_note Monday, 05 Oct 2020
query_builder 14:50 - 15:40
card_travel Panel Discussion
mic English
Panel: How to Negotiate with Big Pharma
The traditional Big Pharma blockbuster model is generally regarded as broken and unsustainable, and there has been marked shift in the R&D model in recent years.  Small pharma companies are now driving innovation and working with Big Pharma companies synergistically to create a faster, more cost-effective way to bring new treatments to market.

Why is this new model so effective? Small pharma companies are agile and focused, remaining unencumbered by the bureaucracy that exists in big pharma.  On the flip side Big Pharma provide the funding and sales and marketing capacity required to support the flow of drugs to market.  It is a co-dependent relationship that can work very well for both sides.

But how can small pharma companies make sure that they are protecting themselves when negotiating deals with Big Pharma?  How do you seek a potential partner and how do you know when you have the best deal that will deliver positive outcomes for you, your team and ultimately the patient?

This information session has been designed to provide you with a well-rounded briefing on everything you need to be aware of as you start negotiations, as well as:

 
  • Ensure you fully understand the reasons for wanting a deal, does it support your business strategy?
  • Enter the deal process with the support of a balanced and experienced team of advisors, and ensure you maintain an open mind throughout the deal making process
  • How to identify the right partner for your organisation, and the importance of having a ‘champion’ within your organisation that you are collaborating with
  • Protect your IP – and ensure you are aware of all the variables of background, foreground, sideground and postground intellectual property matters
  • How to collaborate and negotiate with more than one industry partner
  • What external support services should you consider using during the negotiating process?
  • Who owns the risk when it comes to exit clauses?
  • Be aware of what can go wrong – knowing when to get out when a deal goes wrong
Speakers
Laura Ferguson
Associate Director
AstraZeneca
star star star star star
Legal Drop In Clinic
event_note Monday, 05 Oct 2020
query_builder 15:30 - 17:00
card_travel Drop In Session
mic English
Legal Drop In Clinic
Technical Session Three - Starting with the End in Mind - Choosing the Right Bioprocessing Partner for Success
event_note Monday, 05 Oct 2020
query_builder 15:45 - 16:30
card_travel Technical Session
mic English
Technical Session Three - Starting with the End in Mind - Choosing the Right Bioprocessing Partner for Success
Sponsors
BioLearn Masterclass: Social Media for Beginners
event_note Monday, 05 Oct 2020
query_builder 15:45 - 16:30
card_travel BioLearn Masterclass
mic English
BioLearn Masterclass: Social Media for Beginners
This session will cover:
  • Why use social media and what are the driving forces behind it
  • Where and how to start using social media for business
  • The key features to create a successful social media strategy
  • How to set up and use key social media platforms including Facebook, LinkedIn and Twitter
  • What content to create for your business on social media  
Partnering Meetings
event_note Monday, 05 Oct 2020
query_builder 15:45 - 17:15
card_travel Partnering
mic English
Partnering Meetings
BioLearn Masterclass: How the Drug Discovery Industry Works
event_note Monday, 05 Oct 2020
query_builder 16:30 - 17:15
card_travel BioLearn Masterclass
mic English
BioLearn Masterclass: How the Drug Discovery Industry Works
This Masterclass will cover a brief overview of the following topics in a small group training-session:
  • The commercial landscape
  • Human biology, pathology and drug targets
  • Drug discovery and development
  • Industry pressures and responses
  • Industry in transition
Speakers
Edward Zanders
Owner
PharmaGuide Ltd
star star star star star
Technical Session Four - Advances in Bioproduction
event_note Monday, 05 Oct 2020
query_builder 16:30 - 17:15
card_travel Technical Session
mic English
Technical Session Four - Advances in Bioproduction
Sponsors
Networking Drinks
event_note Monday, 05 Oct 2020
query_builder 17:00 - 18:00
card_travel Social
mic English
Networking Drinks
Processing. Please wait.
Loading...